In vitro-in silico study on the influence of dose, fraction bioactivated and endpoint used on the relative potency value of pyrrolizidine alkaloid N-oxides compared to parent pyrrolizidine alkaloids
-
Published:2024
Issue:
Volume:6
Page:100160
-
ISSN:2666-027X
-
Container-title:Current Research in Toxicology
-
language:en
-
Short-container-title:Current Research in Toxicology
Author:
Alhejji Yasser,
Widjaja FrancesORCID,
Tian Shenghan,
Hoekstra Thomas,
Wesseling Sebastiaan,
Rietjens Ivonne M.C.M.
Funder
European Union
Qassim University
Reference46 articles.
1. Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells;Allemang;Food Chem. Toxicol.,2018
2. Intracellular glutathione plays important roles in pyrrolizidine alkaloids-induced growth inhibition on hepatocytes;Chen;Environ. Toxicol. Pharmacol.,2009
3. Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat;Chen;Food Chem. Toxicol.,2018
4. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica;Chen;Toxicol. Lett.,2020
5. Chou MW, Yan J, Nichols J, Xia Q, Beland FA, Chan P-C, et al. Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice [Cancer Lett. 193 (2003) 119–125]. Cancer Lett. 2004;207(1):119-25.